Legence Corp. Class A Common stock

NASDAQ:LGN

Engineering & Construction

Industrials
$34.85 -0.37%

-$0.32 today

Market cap
$4.82B
Beta
2.93
P/E (TTM)
-254.3
EPS (TTM)
-$0.33
52W Low $26.96High $107.24

Volume 1.58M

Average 1.71M

LGN Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Legence Corp. Class A Common stockNASDAQ: LGN

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How LGN compares with its peers on the latest reported figures

  • LGN's LTM Sep 2026 research & development of $0 is the highest of the 5 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for LGN, versus a peer median of 0.0%.
LGN Competitors Peer median
Research & Development for LGN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LGNLegence Corp. Class A Common stockLTM Sep 2026$0 ——0.0%
FIXComfort Systems USA, Inc.LTM Sep 2026$0 ——0.0%
EMEEMCOR Group, Inc.LTM Jun 2026$0 ——0.0%
AMRCAmeresco, Inc.LTM Mar 2026$0 ——0.0%
LMBLimbach Holdings, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding LGN) $0——0.0%

Competitors are the stored peer set for LGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.25B1.62B2.1B2.55B
Cost of Revenue1.01B1.3B1.67B2.01B
Gross Profit233.71M315.15M428.64M535.93M
Gross Margin18.7%19.5%20.4%21.0%
Research & Development0000
Selling, General & Admin142.05M186.06M252.67M342.63M
Operating Expenses257.95M304.89M370.2M442.99M
Depreciation & Amortization93.02M92.8M110.85M114.29M
EBITDA69.2M107.05M156.62M160.92M
EBITDA Margin5.6%6.6%7.5%6.3%
Operating Income(24.25M)10.26M58.44M92.93M
Operating Margin-1.9%0.6%2.8%3.6%
Interest Income236K4.25M5.46M4.49M
Interest Expense50.84M68.2M25.54M101.78M
Other Income / Expenses(50.41M)(64.2M)(38.21M)(148.08M)
Income Before Tax(74.66M)(53.94M)20.23M(55.14M)
Pre-Tax Margin-6.0%-3.3%1.0%-2.2%
Income Tax Expense7.61M(7.92M)2.81M22.16M
Net Income(82.27M)(46.03M)9.72M(59.78M)
Net Margin-6.6%-2.8%0.5%-2.3%
EPS (Basic)(0.81)(0.45)0.10(1.01)
EPS (Diluted)(0.81)(0.45)0.10(1.01)
Weighted Avg Shares58.51M58.51M58.51M59.38M
Weighted Avg Shares (Diluted)58.51M58.51M58.51M59.38M

Legence Corp. Class A Common stock

NASDAQ:LGN

Intrinsic Alpha fair value

Locked

Current Price

$34.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.